BofA Securities has upgraded Globus Medical (NYSE:GMED) to neutral from underperform, citing the company's strong Q4 revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback